AI assistant
Sun Pharmaceutical Industries Ltd. — M&A Activity 2025
Mar 18, 2025
59215_rns_2025-03-18_ef761986-8420-477b-9b2e-3fff8099648f.pdf
M&A Activity
Open in viewerOpens in your device viewer
Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel.: (91-22) 4324 4324 Fax: (91-22) 4324 4343 Website: www.sunpharma.com Email: [email protected] CIN: L24230GJ1993PLC019050
==> picture [66 x 73] intentionally omitted <==
March 18, 2025
National Stock Exchange of India Limited Scrip Symbol: SUNPHARMA
BSE Limited Scrip Code: 524715
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Update on Acquisition
Further to our intimation dated January 16, 2025, this is to inform that TARO Pharmaceuticals Inc., a subsidiary of Sun Pharmaceutical Industries Limited (together with its subsidiaries and/or affiliates referred to as ‘Sun Pharma’), has completed 100% acquisition of Antibe Therapeutics Inc., Canada for a total consideration of CAD 4.5 million.
For Sun Pharmaceutical Industries Limited
Anoop Digitally signed by Anoop Anjanikumar Anjanikumar Deshpande Date: 2025.03.18 12:21:08 Deshpande +05'30' (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983
Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA.
Reaching People. Touching Lives.